Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/63632
Type
ArticleCopyright
Open access
Collections
- INI - Artigos de Periódicos [3397]
Metadata
Show full item record
REPORT FROM THE WORLD HEALTH ORGANIZATION’S IMMUNIZATION AND VACCINES RELATED IMPLEMENTATION RESEARCH ADVISORY COMMITTEE (IVIR-AC) MEETING, GENEVA, 11–13 SEPTEMBER 2023
Potential of vaccination programmes
Immunization and Vaccine-related Implementation Research Advisory Committee (IVIR-AC)
Author
Affilliation
World Health Organization. Immunizations, Vaccines and Biologicals. Geneva, Switzerland.
Emory University. Atlanta, USA.
University of Cape Town. Modelling and Simulation Hub, Africa. Cape Town, South Africa / Oxford University. Nuffield Department of Medicine. Centre for Global Health. Oxford, United Kingdom.
London School of Hygiene & Tropical Medicine. Department of Infectious Disease Epidemiology. London, United Kingdom.
World Health Organization. Immunizations, Vaccines and Biologicals. Geneva, Switzerland.
Jawaharlal Institute of Postgraduate Medical Education & Research. Puducherry, India.
Qatar University. QU Health. College of Medicine. Qatar.
London School of Hygiene & Tropical Medicine. Centre for Mathematical Modelling of Infectious Diseases. London, United Kingdom.
University of New South Wales. Sydney, Australia.
Seoul National University. Seoul, South Korea.
University of Sydney. School of Public Health. Sydney, Australia.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST e AIDS. Rio de Janeiro, RJ, Brasil.
Consultant. Tanzania.
Johns Hopkins Bloomberg School of Public Health. Baltimore, MD, USA.
Yale School of Public Health. New Haven, CT, USA.
Fudan University. Institutes of Biomedical Sciences. Shanghai, China.
University of Hong Kong. School of Public Health. Hong Kong.
Emory University. Atlanta, USA.
University of Cape Town. Modelling and Simulation Hub, Africa. Cape Town, South Africa / Oxford University. Nuffield Department of Medicine. Centre for Global Health. Oxford, United Kingdom.
London School of Hygiene & Tropical Medicine. Department of Infectious Disease Epidemiology. London, United Kingdom.
World Health Organization. Immunizations, Vaccines and Biologicals. Geneva, Switzerland.
Jawaharlal Institute of Postgraduate Medical Education & Research. Puducherry, India.
Qatar University. QU Health. College of Medicine. Qatar.
London School of Hygiene & Tropical Medicine. Centre for Mathematical Modelling of Infectious Diseases. London, United Kingdom.
University of New South Wales. Sydney, Australia.
Seoul National University. Seoul, South Korea.
University of Sydney. School of Public Health. Sydney, Australia.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST e AIDS. Rio de Janeiro, RJ, Brasil.
Consultant. Tanzania.
Johns Hopkins Bloomberg School of Public Health. Baltimore, MD, USA.
Yale School of Public Health. New Haven, CT, USA.
Fudan University. Institutes of Biomedical Sciences. Shanghai, China.
University of Hong Kong. School of Public Health. Hong Kong.
Abstract
Evaluating vaccine-related research is critical to maximize the potential of vaccination programmes. The WHO Immunization and Vaccine-related Implementation Research Advisory Committee (IVIR-AC) provides an independent review of research that estimates the performance, impact and value of vaccines, with a particular focus on transmission and economic modelling. On 11-13 September 2023, IVIR-AC was convened for a bi-annual meeting where the committee reviewed research and presentations across eight different sessions. This report summarizes the background information, proceedings and recommendations from that meeting. Sessions ranged in topic from timing of measles supplementary immunization activities, analyses of conditions necessary to meet measles elimination in the South-East Asia region, translating modelled evidence into policy, a risk-benefit analysis of dengue vaccine, COVID-19 scenario modelling in the African region, therapeutic vaccination against human papilloma virus, the Vaccine Impact Modelling Consortium, and the Immunization Agenda 2030 vaccine impact estimates.
Keywords
VaccinesPotential of vaccination programmes
Immunization and Vaccine-related Implementation Research Advisory Committee (IVIR-AC)
Share